Hoey Timothy
Officer at TNYA; SVP, Cancer Biology & Co-CSO at OncoMed Pharmaceuticals Inc
- Sold, on record
- $1.3M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Mar 5, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- TNYATenaya Therapeutics, Inc.Officer
- OncoMed Pharmaceuticals IncSVP, Cancer Biology & Co-CSO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- OncoMed Pharmaceuticals Inc66,858 shares
- TNYA27,153 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TNYANo planAug 16 2023
Sold 4,007 shares at $3.81 ($15k)
Hoey Timothy, Chief Scientific Officer
No 10b5-1 planSold 1.5% of holdings ($985k position)254,639 shares leftFiling
- 2 Form 144 notice TNYANoticeAug 29 +13 days
Filed to sell 7,243 shares ($31k)
Hoey Timothy, Officer
10b5-1 planFiling
- 3 Form 4 sale TNYARoutineAug 29 same day
Sold 7,243 shares at $4.26 ($31k)
Hoey Timothy, Chief Scientific Officer
10b5-1 planSold 2.8% of holdings ($1.1M position)247,396 shares leftFollows a Form 144Filing
- 4 Form 4 sale TNYANo planFeb 16 +171 days
Sold 4,681 shares at $5.86 ($27k)
Hoey Timothy, Chief Scientific Officer
No 10b5-1 planSold 1.9% of holdings ($1.4M position)242,715 shares left1.2x usual sizeFiling
- 5 Form 144 notice TNYANoticeFeb 20 +4 days
Filed to sell 6,569 shares ($42k)
Hoey Timothy, Officer
10b5-1 plan1.5x usual sizeFiling
- 6 Form 4 sale TNYARoutineFeb 20 same day
Sold 6,569 shares at $5.34 ($35k)
Hoey Timothy, Chief Scientific Officer
10b5-1 planSold 2.7% of holdings ($1.3M position)236,146 shares left1.5x usual sizeFollows a Form 144Filing
- 7 Form 144 notice TNYANoticeMar 5 +14 days
Filed to sell 20,000 shares ($132k)
Hoey Timothy, Officer
10b5-1 plan4.3x usual sizeFiling
- 8 Form 4 sale TNYARoutineMar 5 same day
Sold 3,300 shares at $7.00 ($23k)
Hoey Timothy, Chief Scientific Officer
10b5-1 planSold 1.3% of holdings ($1.7M position)245,346 shares left0.7x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (21)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | TNYA | Chief Scientific Officer | Form 4 sale | 3,300 | $23k | 1.3% | Routine | SEC |
| Mar 5, 2024 | TNYA | Officer | Form 144 notice | 20,000 | $132k | Notice | SEC | |
| Feb 20, 2024 | TNYA | Chief Scientific Officer | Form 4 sale | 6,569 | $35k | 2.7% | Routine | SEC |
| Feb 20, 2024 | TNYA | Officer | Form 144 notice | 6,569 | $42k | Notice | SEC | |
| Feb 16, 2024 | TNYA | Chief Scientific Officer | Form 4 sale | 4,681 | $27k | 1.9% | No plan | SEC |
| Aug 29, 2023 | TNYA | Chief Scientific Officer | Form 4 sale | 7,243 | $31k | 2.8% | Routine | SEC |
| Aug 29, 2023 | TNYA | Officer | Form 144 notice | 7,243 | $31k | Notice | SEC | |
| Aug 16, 2023 | TNYA | Chief Scientific Officer | Form 4 sale | 4,007 | $15k | 1.5% | No plan | SEC |
| Apr 26, 2022 | TNYA | Chief Scientific Officer | Form 4 sale | 1,353 | $14k | 0.7% | Plan not stated | SEC |
| Apr 4, 2017 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology & Co-CSO | Form 4 sale | 5,754 | $52k | 9.1% | Plan not stated | SEC |
| Jan 3, 2017 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology & Co-CSO | Form 4 sale | 12,763 | $98k | 17.3% | Plan not stated | SEC |
| Nov 16, 2016 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology & Co-CSO | Form 4 sale | 12,500 | $124k | 17.0% | Plan not stated | SEC |
| Jan 7, 2016 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 2,162 | $48k | 4.4% | Plan not stated | SEC |
| Jun 22, 2015 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 5,000 | $130k | 9.2% | Plan not stated | SEC |
| Apr 27, 2015 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 6,887 | $177k | 12.2% | Plan not stated | SEC |
| Feb 5, 2015 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 7,500 | $171k | 13.1% | Unusual | SEC |
| Nov 5, 2014 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 2,500 | $49k | 4.8% | Plan not stated | SEC |
| Aug 5, 2014 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 2,500 | $54k | 4.8% | Plan not stated | SEC |
| May 5, 2014 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 2,500 | $66k | 4.8% | Plan not stated | SEC |
| Mar 5, 2014 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 1,792 | $64k | 5.8% | Plan not stated | SEC |
| Feb 5, 2014 | OncoMed Pharmaceuticals Inc | SVP, Cancer Biology | Form 4 sale | 5,000 | $151k | 14.6% | Plan not stated | SEC |